Articles dans des revues avec comité de lecture (149)
  1. 69. Vandurm, P., Guiguen, A., Cauvin, C., Georges, B., Le Van, K., Michaux, C., Cardona, C., Mbemba, G., Mouscadet, J.-F., Hevesi, L., Van Lint, C., & Wouters, J. (2011). Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition. European journal of medicinal chemistry, 46(5), 1749-1756. doi:10.1016/j.ejmech.2011.02.028
  2. 70. Colin, L., Vandenhoudt, N., De Walque, S., Van Driessche, B., Bergamaschi, A., Martinelli, V., Cherrier, T., Vanhulle, C., Guiguen, A., David, A., Burny, A., Herbein, G., Pancino, G., Rohr, O., & Van Lint, C. (2011). The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for viral replication. PloS one, 6(4), e19084. doi:10.1371/journal.pone.0019084
  3. 71. Redel, L., Le Douce, V., Cherrier, T., Marban, C., Janossy, A., Aunis, D., Van Lint, C., Rohr, O., & Schwartz, C. (2010). HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes. Journal of leukocyte biology, 87, 575-588. doi:10.1189/jlb.0409264
  4. 72. Pierard, V., Guiguen, A., Colin, L., Wijmeersch, G., Vanhulle, C., Van Driessche, B., Dekoninck, A., Blazkova, J., Cardona, C., Merimi, M., Vierendeel, V., Calomme, C., Nguyen, T. L.-A., Nuttinck, M., Twizere, J.-C., Kettmann, R., Portetelle, D., Burny, A., Hirsch, I., Rohr, O., & Van Lint, C. (2010). DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: Potential involvement of direct inhibition of CREB/CREM/ATF transcription factor binding. The Journal of biological chemistry. doi:10.1074/jbc.M110.107607
  5. 73. Lens, Z., Dewitte, F., Monte, D., Baert, J.-L., Bompard, C., Sénéchal, M., Van Lint, C., De Launoit, Y., Villeret, V., & Verger, A. (2010). Solution structure of the N-terminal transactivation domain of ERM modified by SUMO-1. Biochemical and biophysical research communications, 399(1), 104-110. doi:10.1016/j.bbrc.2010.07.049
  6. 74. Trono, D., Van Lint, C., Rouzioux, C., Verdin, E., Barré-Sinoussi, F., Chun, T.-W., & Chomont, N. (2010). HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science, 329(5988), 174-180. doi:10.1126/science.1191047
  7. 75. Colin, L., & Van Lint, C. (2009). Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology, 6, 111. doi:10.1186/1742-4690-6-111
  8. 76. Vandurm, P., Cauvin, C., Guiguen, A., Georges, B., Le Van, K., Martinelli, V., Cardona, C., Mbemba, G., Mouscadet, J.-F., Hevesi, L., Van Lint, C., & Wouters, J. (2009). Structural and theoretical studies of [6-bromo-1-(4-fluorophenylmethyl)-4(1H)-quinolinon-3-yl)]-4-hydroxy-2-oxo-3-butenoïc acid as HIV-1 integrase inhibitor. Bioorganic & medicinal chemistry letters, 19(16), 4806-4809. doi:10.1016/j.bmcl.2009.06.044
  9. 77. Vire, B., De Walque, S., Restouin, A., Olive, D., Van Lint, C., & Collette, Y. (2009). Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions. PloS one, 4(9), e7085. doi:10.1371/journal.pone.0007085
  10. 78. Reuse, S., Calao, M., Kabeya, K., Guiguen, A., Gatot, J.-S., Quivy, V., Vanhulle, C., Lamine, A., Vaira, D., Demonte, D., Martinelli, V., Veithen, E., Cherrier, T., Avettand, V., Poutrel, S., Piette, J., De Launoit, Y., Moutschen, M., Burny, A., Rouzioux, C., De Wit, S., Herbein, G., Rohr, O., Collette, Y., Lambotte, O., Clumeck, N., & Van Lint, C. (2009). Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PloS one, 4(6), e6093. doi:10.1371/journal.pone.0006093
  11. 79. Le Van, K., Cauvin, C., De Walque, S., Georges, B., Boland, S., Martinelli, V., Demonte, D., Durant, F., Hevesi, L., & Van Lint, C. (2009). New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors. Journal of medicinal chemistry, 52(12), 3636-3643. doi:10.1021/jm801438e
  12. 80. Cherrier, T., Suzanne, S., Redel, L., Calao, M., Marban, C., Samah, B., Mukerjee, R., Schwartz, C., Gras, G., Sawaya, B. E., Zeichner, S. L., Aunis, D., Van Lint, C., & Rohr, O. (2009). p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene, 28(38), 3380-3389. doi:10.1038/onc.2009.193
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 Suivant >>